Respiratory pathogens pose a global threat, triggering outbreaks and severe symptoms that can have devastating consequences. Respiratory tract infections, which affect the upper and lower respiratory tracts, are a major cause of mortality, especially among immunocompromised patients, although these diseases affect people of all ages throughout the world.
Against this backdrop, Vitro’s range of diagnostic reagents are designed for the accurate detection and differentiation of influenza, the SARS-CoV-2 virus and possible co-infections during periods of respiratory disease. We are committed to ensuring that patients receive appropriate treatment promptly, thereby optimising clinical outcomes. Detecting other respiratory viruses that cause acute illness ensures comprehensive coverage, allowing a variety of respiratory pathogens to be identified.
Discover our respiratory virus detection kits. Based on one-step RT-PCR and RT-PCR Multiplex + reverse hybridisation on a membrane using DNA Flow technology.